Cargando…

PD-1 mRNA expression in peripheral blood cells and its modulation characteristics in cancer patients

Immune checkpoint inhibitors that block the PD-1/PD-L1 signaling pathway have been used to treat a wide variety of cancers. Although results have been promising, significant inter-individual and inter-tumor variability has been observed. It is believed that better clinical outcome could be achieved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wei, Shen, Ge, Wu, Shikai, Song, Shiping, Ni, Yanli, Suo, Zhuoyao, Meng, Xiangying, Li, Dan, Zhou, Lin, Hao, Rimin, Zhao, Yaowei, Bai, Li, Hou, Lili, Liu, Bing, Liu, Guangxian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584204/ https://www.ncbi.nlm.nih.gov/pubmed/28881603 http://dx.doi.org/10.18632/oncotarget.15006

Ejemplares similares

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients
por: Liu, Chao, et al.
Publicado: (2018)

Effect of an immunomodulatory regimen for cancer prevention: A case report
por: Wang, Wenbo, et al.
Publicado: (2016)

Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy
por: Liu, Chao, et al.
Publicado: (2017)

Fundamental effects of PD-1 antibody on the body: a brief report
por: Wang, Wei, et al.
Publicado: (2016)

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease
por: Liu, Chao, et al.
Publicado: (2018)

Clinical analysis of three patients with multiple endometrial cancer lesions treated by hysteroscopic surgery combined with progesterone: Case report
por: Wang, Li, et al.
Publicado: (2023)

Everolimus (RAD001) combined with programmed death-1 (PD-1) blockade enhances radiosensitivity of cervical cancer and programmed death-ligand 1 (PD-L1) expression by blocking the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) pathway
por: Song, Lili, et al.
Publicado: (2022)

A nomogram for predicting survival in patients with breast cancer brain metastasis
por: Huang, Zhou, et al.
Publicado: (2018)

Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer
por: Wang, Qian, et al.
Publicado: (2019)

Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases
por: Xuan, Liang, et al.
Publicado: (2020)

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

Peripheral CD8+CD28+ T lymphocytes predict the efficacy and safety of PD-1/PD-L1 inhibitors in cancer patients
por: Geng, Ruixuan, et al.
Publicado: (2023)

Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case report
por: Sun, Bing, et al.
Publicado: (2016)

Brain metastasis reirradiation in patients with advanced breast cancer
por: Huang, Zhou, et al.
Publicado: (2017)

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer
por: Liu, Chao, et al.
Publicado: (2016)

Immunomodulatory features of radiotherapy in lung carcinoma
por: Shen, Ge, et al.
Publicado: (2020)

Screening and identification of an anti-PD-1 nanobody with antitumor activity
por: Zhang, Yanting, et al.
Publicado: (2023)

Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report
por: Meng, Xiangying, et al.
Publicado: (2017)

Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancer
por: Sun, Bing, et al.
Publicado: (2016)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

Establishment of a Colorectal Cancer-Related MicroRNA-mRNA Regulatory Network by Microarray and Bioinformatics
por: Jiang, Dan, et al.
Publicado: (2020)

Regulatory Effect of PD1/PD-Ligand 1 (PD-L1) on Treg Cells in Patients with Idiopathic Pulmonary Fibrosis
por: Wang, Bing, et al.
Publicado: (2021)

Receptor conversion in metastatic breast cancer: a prognosticator of survival
por: Meng, Xiangying, et al.
Publicado: (2016)

Cell metabolism pathways involved in the pathophysiological changes of diabetic peripheral neuropathy
por: Lv, Yaowei, et al.
Publicado: (2023)

Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer
por: Ma, Yangyang, et al.
Publicado: (2023)

PD‐1 mRNA expression in peripheral blood mononuclear cells as a biomarker for different stages of primary gouty arthritis
por: Su, Jing, et al.
Publicado: (2020)

From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
por: Zhao, Xuan, et al.
Publicado: (2022)

Management of traumatic peripheral artery pseudoaneurysm: A 10-year experience at a single center
por: Wang, Yingliang, et al.
Publicado: (2022)

Molecular Mechanism of Expression Changes of Immunological Indexes of PD-1/sPD-L1 after Radiotherapy in Nonsmall Cell Lung Cancer
por: Qu, Yanli, et al.
Publicado: (2021)

Single cell sequencing revealed the mechanism of PD-1 resistance affected by the expression profile of peripheral blood immune cells in ESCC
por: Deng, Ting, et al.
Publicado: (2022)

Integrated analysis of microRNA and mRNA expression profiles in Crassostrea gigas to reveal functional miRNA and miRNA-targets regulating shell pigmentation
por: Feng, Dandan, et al.
Publicado: (2020)

EV PD-L1 Contributes to Immunosuppressive CD8(+) T Cells in Peripheral Blood of Pediatric Wilms Tumor
por: Zhang, Xiaoxue, et al.
Publicado: (2021)

Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment
por: Su, Qiang, et al.
Publicado: (2018)

Downregulation of the PD-1/PD-Ls pathway in peripheral cells correlates with asbestosis severity
por: Qiu, Meihua, et al.
Publicado: (2021)

PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment
por: Su, Qiang, et al.
Publicado: (2017)

miR-375 Modulates Radiosensitivity of HR-HPV-Positive Cervical Cancer Cells by Targeting UBE3A through the p53 Pathway
por: Song, Lili, et al.
Publicado: (2015)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

“Biqi” Bayberry Extract Promotes Skeletal Muscle Fiber Type Remodeling by Increasing Fast Myofiber Formation via the Akt/FoxO1 Pathway in Mice
por: Li, Jinjie, et al.
Publicado: (2023)

A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy
por: Zheng, Min, et al.
Publicado: (2012)

Up-regulated expression of oxytocin mRNA in peripheral blood lymphocytes from first-episode schizophrenia patients
por: Yang, Xiudeng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g1p3s6d1em67sbqjlmp2m3aeck